09.07.2019 Views

Diagnostic Ultrasound - Abdomen and Pelvis

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prostatic Hyperplasia<br />

526<br />

Diagnoses: Urinary Tract<br />

○ Sonographic appearance of BPH is variable, depending<br />

on histopathologic changes<br />

– Diffusely enlarged TZ; heterogeneous, nodular<br />

– ± calcification of corpora amylacea → prostatic calculi<br />

– ± cystic degeneration of BPH nodules<br />

○ Potential secondary changes of bladder <strong>and</strong> upper<br />

urinary tracts are best seen transabdominally<br />

– Possible bladder findings: Wall<br />

thickening/trabeculation, diverticula, stones,<br />

abnormal postvoid residual (PVR)<br />

– Possible upper tract changes: Ureteral dilation,<br />

hydronephrosis<br />

• Color Doppler<br />

○ Normal prostate is moderately vascular<br />

○ Vascularity is usually higher in malignancy <strong>and</strong> prostatitis<br />

than in BPH<br />

• Power Doppler<br />

○ Cannot reliably differentiate BPH from prostatic cancer<br />

Imaging Recommendations<br />

• Best imaging tool<br />

○ <strong>Ultrasound</strong> is typically not needed in BPH management<br />

but may be obtained to investigate BPH as cause of renal<br />

insufficiency → measure prostate size <strong>and</strong> PVR, evaluate<br />

for upper tract obstruction<br />

DIFFERENTIAL DIAGNOSIS<br />

Prostate Carcinoma<br />

• Commonly originates in PZ (70%)<br />

• Classically described as hypervascular hypoechoic PZ nodule<br />

but is difficult to differentiate cancer from BPH, prostatitis<br />

<strong>and</strong> other nonmalignant entities<br />

Prostatitis<br />

• Variable, may be normal<br />

○ Main role of US is to exclude prostatic abscess<br />

• Acute: Enlarged gl<strong>and</strong>; diffuse or focal hypoechogenicity<br />

with focal or global hypervascularity; may mimic carcinoma<br />

• Chronic: Abnormalities may be diffuse or only in the<br />

periurethral or peripheral areas<br />

○ Scattered hypoechoic areas in PZ; hyperechoic regions<br />

with hypoechoic halos; focal or diffuse hypervascularity;<br />

ejaculatory duct calcifications; thick/irregular capsule<br />

Bladder Carcinoma<br />

• Enlarged median lobe in BPH simulates bladder mass<br />

PATHOLOGY<br />

General Features<br />

• Etiology<br />

○ Nodular periurethral stromal <strong>and</strong> epithelial hyperplasia<br />

○ BOO from BPH may occur from urethral constriction<br />

from increased smooth muscle tone <strong>and</strong> resistance<br />

(dynamic) &/or urethral compression from gl<strong>and</strong><br />

enlargement (static)<br />

○ All BPH nodules develop in TZ or periurethral region<br />

Gross Pathologic & Surgical Features<br />

• Enlarged, rubbery gl<strong>and</strong> at prostatectomy<br />

Microscopic Features<br />

• Hyperplastic nodules due to gl<strong>and</strong>ular &/or fibrous or<br />

muscular stromal proliferation<br />

CLINICAL ISSUES<br />

Presentation<br />

• Most common signs/symptoms<br />

○ Asymptomatic or LUTS<br />

○ Size of prostate does not correlate with severity of<br />

symptoms or urodynamic changes<br />

• Other signs/symptoms<br />

○ Urinary incontinence: Overflow or urge<br />

○ Hematuria<br />

○ UTI<br />

○ Acute urinary retention<br />

• Clinical profile<br />

○ Enlarged prostate on rectal exam<br />

○ May have elevated prostate-specific antigen (PSA)<br />

○ Possible bladder sequelae: Trabeculation, diverticula,<br />

calculi, detrusor muscle failure<br />

○ Possible upper tract changes: Ureterectasis,<br />

hydronephrosis<br />

– Can be from secondary vesicoureteral reflux,<br />

obstruction from muscular hypertrophy or angulation<br />

at ureterovesical junction, sustained high pressure<br />

bladder storage<br />

Demographics<br />

• Epidemiology<br />

○ Affects 70% of men by age 60-69 years; 80% of those<br />

aged 70-80 years; 90% men aged 80-90 years<br />

Natural History & Prognosis<br />

• May lead to detrusor muscle failure, renal insufficiency<br />

Treatment<br />

• Options, risks, complications<br />

○ Noninvasive: No therapy if asymptomatic or no<br />

bothersome symptoms<br />

– If bothersome symptoms, then drug therapy is first<br />

line<br />

○ Minimal invasive & surgical options if drug therapy fails<br />

– Transurethral: Resection of the prostate (TURP),<br />

incision of the prostate (TUIP), microwave<br />

thermotherapy (TUMT), needle ablation (TUNA), laser<br />

– Embolization<br />

– Simple prostatectomy, open or robot-assisted<br />

DIAGNOSTIC CHECKLIST<br />

Consider<br />

• Prostate carcinoma or prostatitis<br />

Image Interpretation Pearls<br />

• Median lobe hyperplasia may simulate bladder mass<br />

SELECTED REFERENCES<br />

1. Trabulsi E, Halpern E, Gomella L. (2012). Ultrasonography <strong>and</strong> Biopsy of the<br />

Prostate. In Campbell-Walsh Urology (10th ed., pp. 2735-2747). Philadelphia:<br />

Saunders.<br />

2. Roehrborn, C. (2012). Benign Prostatic Hyperplasia. In Wein AJ, et al (Ed),<br />

Campbell-Walsh Urology (10th edition, pp 2570-2610). Philadelphia:<br />

Saunders.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!